Managing intellectual property and technology transfer inquiry
Inquiry by the Science and Technology Committee (Commons), 28 June 2016 to 3 May 2017. Its page on the Parliament website.
Reports and responses
Evidence sessions
- 2 November 2016: Dr Tony Raven, Chief Executive, Cambridge Enterprise, Nick Sturge, Director, Engine Shed, University of Bristol, and Dr Claire Brady, Head of Technology Transfer, Edinburgh Research and Innovation, The University of Edinburgh; Dr Phil Clare, Chair, Advocacy Committee, PraxisUnico, Dr Rosa Fernández, Research Director, National Centre for Universities and Business, and Dr Toby Basey-Fisher, Chief Executive, Eva Diagnostics
- 22 November 2016: Dr Will West, Executive Chairman, CellCentric and Member, BioIndustry Association Board, Felicity Burch, Head of Innovation and Digital, CBI, and Richard North, Head of IP Protection Licensing and Control, Rolls-Royce; Anne Glover, Co-founder and Chief Executive, Amadeus Capital Partners Ltd, Chris Mairs, Venture Partner, Entrepreneur First, and Mike Conroy, Executive Director, Corporate and Commercial Banking, British Bankers’ Association
- 14 December 2016: Mark Anderson, The Law Society IP Law Committee, and Dr Daniel Nelki, Science to Health Lead, Wellcome Trust; Professor Dame Ann Dowling, President, Royal Academy of Engineering, and Professor Trevor McMillan, Vice-Chancellor, Keele University
- 11 January 2017: Joseph Johnson MP, Minister for Universities, Science, Research and Innovation, Jenny Dibden, Director of Science and Research, Department for Business, Energy and Industrial Strategy, and Sean Dennehey, Acting Chief Executive and Comptroller General, Intellectual Property Office.